Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AVTX Avalo Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $16.17 -2.4% | $15.86 +5.3% |
| StockIQ Score | 35F Weak Risk: Medium | 38F Weak Risk: Medium |
| Technical | 5F | 21F |
| Fundamental | 39F | 35F |
| Growth | 46D+ | 50C- |
| Fair Value | 55C | 38F |
| News | 38F | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Avalo Therapeutics (AVTX) scores higher in technical (39 vs. 18) and valuation (50 vs. 38) metrics, showing stronger short-term price trends and perceived market value. Ascentage Pharma (AAPG) leads in growth (50 vs. 46), indicating faster expected revenue or earnings expansion. Both carry a "WEAK" rating, but AVTX’s higher technical score suggests slightly more stability in trading activity.
